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The ependyma is a single-layered, ciliated epithelium at
the interface between the parenchyma of the central nerv-
ous system and the ventricular space. Recently, it has been
implicated in the pathogenesis of hydrocephalus, a debil-
itating dilation of the cerebral ventricles at the expense of
the brain parenchyma. We have previously identified
marker proteins for ependymal differentiation and kinoc-
ilia generation, namely SCO-C3 and putative adenylate
kinase 7 (pAK7). In order to functionally characterize
these proteins, it is desirable to introduce corresponding
expression and RNAi constructs into our ependymal pri-
mary culture model system. However, polyciliated epend-
ymal cells in the primary cultures were found to be
completely resistant to transfection with naked plasmid
DNA, necessitating more efficient means of nucleic acid
transfer. Therefore, a lentiviral vector system based on
pseudotyped human immunodeficiency virus (HIV) was
established. HIV pseudotyped with the vesicular stomati-
tis virus envelope protein (VSV-G) and bearing constructs
encoding either SCO-C3 or pAK7 were generated and ver-
ified for infectivity by successful production of stable
HEK293T cell lines expressing the respective proteins. As
reported by others, the ependyma is easily transfected by
HIV/VSV-G in vivo. However, treatment of ependymal pri-
mary cultures with this vector resulted in the transfection
of only a few polyciliated ependymal cells. While the cur-
rent transfection efficiency may be insufficient for the
proper analysis of target proteins, the principal feasibility
of lentiviral transfection of ependymal primary cultures
has nevertheless been demonstrated. In order to improve
the transfection efficiency, other HIV pseudotypes includ-
ing HIV/Mokola virus envelope protein, HIV/Rabies virus
envelope protein and HIV/Ebola virus envelope protein
are being tested. As a byproduct of vector testing, we
obtained HEK293T cell lines coexpressing pAK7 frag-
ments and putative pAK7 interaction partners that had
previously been identified by yeast two-hybrid screens.
These cell lines are now being used to yield additional evi-
dence for the corresponding protein-protein interactions.
Cell lines expressing SCO-C3 and pAK7 were further used
to test the efficacy of RNAi constructs introduced by other
lentiviral vectors. An RNAi sequence yielding almost com-
plete knockdown of pAK7 expression was identified. The
successful anti-pAK7 lentivirus is now ready for use in
pAK7 knockdown studies both in vitro and in vivo.
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